Zhonghui H Fan

6500571, Dec 31, 2002

Aug 18, 1999

09/376792

Michael James Liberatore - Lawrenceville NJ
Leszek Hozer - West Windsor NJ
Attiganal Narayanaswamy Sreeram - Edison NJ
Rajan Kumar - Robbinsville NJ
Chetna Bindra - Piscataway NJ
Zhonghui Hugh Fan - Plainsboro NJ

PowerZyme, Inc. - Monmouth Junction NJ

H01M 816

429 2

Provided is a fuel cell comprising a first compartment, a second compartment and a barrier separating the first and second compartments, wherein the barrier comprises a proton transporting moiety.

20030039868, Feb 27, 2003

Aug 23, 2002

10/226841

Michael Liberatore - Lawrenceville NJ, US
Leszek Hozer - West Windsor NJ, US
Attiganal Sreeram - Edison NJ, US
Rajan Kumar - Robbinsville NJ, US
Chetna Bindra - Piscataway NJ, US
Zhonghui Fan - Plainsboro NJ, US

H01M008/10
H01M008/16
H01M010/40

429/002000, 429/013000, 429/033000, 429/050000, 429/105000

Provided is a battery comprising a first compartment, a second compartment and a barrier separating the first and second compartments, wherein the barrier comprises a proton transporting moiety.

20050158618, Jul 21, 2005

Mar 3, 2005

11/071075

Michael Liberatore - Jersey City NJ, US
Leszek Hozer - West Windsor NJ, US
Attiganal Sreeram - Edison NJ, US
Rajan Kumar - Robbinsville NJ, US
Chetna Bindra - Piscataway NJ, US
Zhonghui Fan - Plainsboro NJ, US

PowerZyme, Inc. - Monmouth Junction NJ

H01M008/20
H01M010/44

429105000, 429050000

Provided is a battery comprising a first compartment, a second compartment and a barrier separating the first and second compartments, wherein the barrier comprises a proton transporting moiety.

20100093559, Apr 15, 2010

Mar 27, 2008

12/527574

Zhonghui Fan - Gainesville FL, US
Toshikazu Nishida - Gainesville FL, US

C40B 30/04
C40B 60/12

506 9, 506 39

(A1+A3, B1−B3, C1−C3) Disclosed herein are microfluidic devices having an array of microfluidic valves and other components to meet the requirement of an antibody array for analyte detection. The microfluidic valves disclosed herein enable simultaneous detection of multiple analytes in a sample. One embodiment exemplified herein pertains to a microarray that is in the format of a sandwich assay, each of which comprises a capture antibody, analyte, and secondary detection antibody conjugated with a fluorescent dye or an enzyme or another moiety to facilitate detection. Methods of using microfluidic valves in an array for simultaneously detecting multiple analytes is also disclosed.

62967525, Oct 2, 2001

Jun 4, 1999

9/326139

Sterling Eduard McBride - Lawrenceville NJ
Satyam Choudary Cherukuri - Princeton NJ
Rajan Kumar - Robbinsville NJ
Judith Ann Ladd - Hamilton NJ
Zhonghui Hugh Fan - Plainsboro NJ
Bryan Lloyd Bentz - Princeton NJ
Peter J. Zanzucchi - Lawrenceville NJ

Sarnoff Corporation - Princeton NJ

G01N 2726
G01N 24447

204547

Provided is an apparatus for separating, in a medium, a component from a composition comprising: (1) an array of three or more electrodes arrayed along a pathway along which molecules of the composition are transported; and (2) a power source device for delivering to voltage to the electrodes; wherein the voltages delivered to the electrode array by the power source device are effective to: (a) alter the relative movement along the transport pathway of two or more of the molecules caused by a motive force, or (b) cause the molecules to move along the transport pathway.

58463968, Dec 8, 1998

Nov 9, 1995

8/556036

Peter John Zanzucchi - West Windsor Township, Mercer County NJ
Satyam Choudary Cherukuri - Cranbury NJ
Sterling Edward McBride - Lawrence Township, Mercer County NJ
Robert R. Demers - Cranbury NJ
Aaron W. Levine - Lawrenceville NJ
Barry Jay Thaler - Lawrenceville NJ
Robert Leon Quinn - Trenton NJ
Paul Leonard Braun - Highland Park NJ
William Chiang - Monmouth Junction NJ
Zhonghui Hugh Fan - Plainsboro NJ
Steven A. Lipp - Cranbury NJ
James R. Matey - Mercerville NJ

Sarnoff Corporation - Princeton NJ

G01N 2726
G01N 2100
B01L 1100

204601

The present invention provides a liquid distribution system, which is useful in a number of contexts, including in accomplishing various synthetic, diagnostic and drug screening reactions. The distribution system can comprise an alpha reservoir and a beta reservoir, a first set of parallel and adjacent first and second feeder channels and a second set of parallel and adjacent third and fourth feeder channels which are offset from the first and second feeder channels, wherein (a) the first and third feeder channels are connected to the alpha reservoir via a first connector channel that is situated above or below the second and fourth feeder channels and are independent of the beta reservoir and (b) the second and fourth feeder channels are connected to the beta reservoir via a second connector channel that is situated above or below the first and third feeder channels and are independent of the alpha reservoir. The distribution system is preferably a microscale distribution system. Various particular mechanisms for controlling flow into a liquid distribution system are described.

59928204, Nov 30, 1999

Nov 19, 1997

8/974258

Thomas Louis Fare - Yardley PA
Zhonghui Hugh Fan - Plainsboro NJ
Paul James Heaney - Skillman NJ

Sarnoff Corporation - Princeton NJ

G01N 2726

25112901

Provided is a fluid control device comprising: (a) a channel of capillary dimensions for conveying a liquid, (b) a bubble-forming device for forming a channel-blocking bubble in the channel, wherein such a bubble formed in the channel impedes the flow of the liquid through the channel.

20210102265, Apr 8, 2021

Nov 25, 2020

17/104525

- Gainesville FL, US
Xiao JIANG - Gainesville FL, US
Maohua PAN - Gainesville FL, US
John LEDNICKY - Gainesville FL, US
Alexandros Demetrios THEODORE - Plantation FL, US
Zhonghui Hugh FAN - Gainesville FL, US
Nima AFSHAR MOHAJER - Baltimore MD, US

C12Q 1/70
G01N 33/569

Described herein are bioaerosol detection systems and methods of use. In embodiments of bioaerosol detection systems and methods of use as described herein, systems and methods detect one or more coronaviruses and/or one or more influenza strains. In embodiments, coronaviruses according to systems and methods as described herein are SARS-CoV-2 coronavirus. In embodiments, influenza strains and/or particles according to the present disclosure are H1N1 influenza.